Cellectar receives fda fast track designation for clr 131 in lymphoplasmacytic lymphoma/waldenstrom’s macroglobulinemia

Cellectar receives fda fast track designation for clr 131 in lymphoplasmacytic lymphoma/waldenstrom’s macroglobulinemia.
CLRB Ratings Summary
CLRB Quant Ranking